Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Share News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,770.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.226%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,770.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ex-Genus Boss Wood To Chair ECO Animal Health As Founder Departs

Thu, 07th Mar 2019 11:47

LONDON (Alliance News) - ECO Animal Health Group PLC announced Thursday Founder & Non-Executive Chair Peter Lawrence will be leaving after almost 50 years.

Lawrence, who founded ECO Animal Health in 1972, has departed with immediate effect.

Stepping up will be Richard Wood, who has "considerable" experience in the global animal health sector, ECO Animal Health said.

Wood is a former chief executive of FTSE 250 biotechnology firm Genus PLC, having led the firm for 14 years until 2011.

Chief Executive Marc Loomes said: "On behalf of the board I would like to sincerely thank Peter for his enormous contribution to the growth and development of the company during his time with the business.

"We are delighted Richard has agreed to take over the role of chair, as he brings significant sector and City experience to the board. This experience will help support the expansion plans of ECO Animal Health, including investment in product development programmes and the broadening of our portfolio offer and new geographical presence."

Eco shares were untraded Thursday, last quoted at 460 pence each.

More News
28 Jun 2021 19:35

TRADING UPDATES: Anglo-Eastern tips palm oil price fall; DX expands

TRADING UPDATES: Anglo-Eastern tips palm oil price fall; DX expands

Read more
22 Jun 2021 20:34

IN BRIEF: Genus trial shows gene edited pigs resistant to PRRS virus

IN BRIEF: Genus trial shows gene edited pigs resistant to PRRS virus

Read more
22 Jun 2021 07:50

Genus provides update on PRRS virus resistance programme

(Sharecast News) - Animal genetics company Genus provided an update on its porcine reproductive and respiratory syndrome virus resistance programme as part of its capital markets event on Tuesday.

Read more
31 Mar 2021 17:13

DIRECTOR DEALINGS: Sealand Capital chair invests amid licence talks

DIRECTOR DEALINGS: Sealand Capital chair invests amid licence talks

Read more
31 Mar 2021 12:17

LONDON MARKET MIDDAY: Biden spends big; Deliveroo dives on debut

LONDON MARKET MIDDAY: Biden spends big; Deliveroo dives on debut

Read more
31 Mar 2021 09:37

BROKER RATINGS: BP cut by Morgan Stanley; Jefferies raises Hikma

BROKER RATINGS: BP cut by Morgan Stanley; Jefferies raises Hikma

Read more
25 Mar 2021 16:03

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
22 Mar 2021 14:07

IN BRIEF: Genus adds molecular biology head Jason Chin to board

IN BRIEF: Genus adds molecular biology head Jason Chin to board

Read more
26 Feb 2021 16:23

DIRECTOR DEALINGS: Hochschild, Wizz Air, Clipper Logistics Execs Sell

DIRECTOR DEALINGS: Hochschild, Wizz Air, Clipper Logistics Execs Sell

Read more
25 Feb 2021 17:04

LONDON MARKET CLOSE: Stocks Edge Lower As US Bond Yields Rise

LONDON MARKET CLOSE: Stocks Edge Lower As US Bond Yields Rise

Read more
25 Feb 2021 16:15

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
25 Feb 2021 13:49

Thursday broker round-up

(Sharecast News) - Medica Group: Liberum initiates at buy with a target price of 200p.

Read more
25 Feb 2021 12:04

LONDON MARKET MIDDAY: Stocks Notch Moderate Gains Ahead Of US Data

LONDON MARKET MIDDAY: Stocks Notch Moderate Gains Ahead Of US Data

Read more
25 Feb 2021 09:42

Genus Posts "Very Strong" Interim Results Despite Covid-19 Impact

Genus Posts "Very Strong" Interim Results Despite Covid-19 Impact

Read more
25 Feb 2021 09:33

BROKER RATINGS: AstraZeneca, Reckitt And Tesco Receive Upgrades

BROKER RATINGS: AstraZeneca, Reckitt And Tesco Receive Upgrades

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.